NCT00210470 2020-12-11A Phase 2 Clinical Trial of the Safety and Effects of IRX-2 in Treating Patients With Operable Head and Neck CancerBrooklyn ImmunoTherapeutics, LLCPhase 2 Completed27 enrolled 16 charts
NCT01581970 2019-09-11Potentiation of Cetuximab by Tregs Depletion With CSA in Advanced Head & Neck CancerMasonic Cancer Center, University of MinnesotaPhase 2 Completed7 enrolled 9 charts
NCT00007982 2013-02-04Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Patients With Central Nervous System CancerNational Cancer Institute (NCI)Phase 2 Completed30 enrolled